Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumab

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|11|2004-2011

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.11, 2015-11, pp. : 2004-2011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : e27-e29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Horse anti‐thymocyte globulin and eculizumab as concomitant therapeutic approach in an aplastic paroxysmal nocturnal hemoglobinuria patient: go or no‐go?

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 97, Iss. 4, 2016-10 ,pp. : 403-405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal Involvement in Paroxysmal Nocturnal Hemoglobinuria

By  

Nephron Clin Pract, Vol. 123, Iss. 1-2, 2013-06 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Paroxysmal Nocturnal Hemoglobinuria after Autologous Stem Cell Transplantation: Extinction of the Clone during Treatment with Eculizumab – Pathophysiological Implications of a Unique Clinical Case

By  

Acta Haematologica, Vol. 126, Iss. 2, 2011-05 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

A Rapid Spectrophotometric Screening Assay for Paroxysmal Nocturnal Hemoglobinuria

By  

Acta Haematologica, Vol. 107, Iss. 3, 2002-04 ,pp. : 182-184

Karger

Access to resources Recommend Favorite